Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-014239
Filing Date
2025-02-14
Accepted
2025-02-14 16:44:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11922
  Complete submission text file 0001104659-25-014239.txt   13720
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-45181 | Film No.: 25630141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8 SOUND SHORE DRIVE SUITE 210 GREENWICH CT 06830
Business Address 8 SOUND SHORE DRIVE SUITE 210 GREENWICH CT 06830 2035698920
Greenhaven Road Investment Management, L.P. (Filed by) CIK: 0001741129 (see all company filings)

EIN.: 364837161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A